NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
Smart Glasses, Lunar Logistics and Simpler Diabetes Care Offer a Compelling Growth Theme
Wall Street’s most interesting growth stories do not always share an industry. Sometimes they share a commercial breakthrough: making something difficult easier to buy, use or deliver. Warby Parker…
New Patient Research Strengthens the Case for MODD's Pivot
Medical technology often competes by adding features. Modular Medical (NASDAQ:MODD) is pursuing a different proposition: make insulin delivery less demanding for the people who must manage it every day. New patient research announced…
Healthcare’s most compelling growth stories often begin with an unglamorous proposition: make an existing problem less difficult to manage. For INOVIO Pharmaceuticals (NASDAQ: INO), that means a newly approved immunotherapy intended to reduce repeated surgeries. For IDEXX Laboratories (NASDAQ: IDXX), it means…
From SK hynix’s record results to Modular Medical’s European preparations, investors have more than one reason to look beyond interest-rate anxiety.
October 28, 2026
Wall Street does not need every company to thrive at once. It needs enough businesses to demonstrate that…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
A national pharmacy benefit manager contract, new digital learning tools and a focused launch strategy give the insulin-pump developer a more concrete commercial narrative.
Modular Medical, Inc. (NASDAQ: MODD) is assembling something many tend to appreciate more than another promising product presentation:…
Beta Bionics, Inc. (NASDAQ: BBNX) has priced a $150 million public offering this week just as its product story is acquiring more commercial torque: FDA clearance for the Mint™ patch pump, a planned U.S. launch in the first quarter of 2027, and a…
